Evidence map›Paper›PMID 41221382›Full record

ReviewWorld journal of nuclear medicine2025

Theranostic Radioembolization: Radiation Dosimetry-Guided Treatment Planning and Delivery.

Dale L Bailey, Elizabeth J Bernard, Richard Maher, Albert C Goh, Yaser H Gholami, Nick Pavlakis, Kathy P Willowson

Abstract readReview
In one paragraph

Review in World journal of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Theranostics Implementation: Opportunities and Challenges.World journal of nuclear medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dale L BaileyDepartment of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia.ORCID 0000-0001-9154-7957
Elizabeth J BernardDepartment of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia.ORCID 0009-0008-9085-8823
Richard MaherDepartment of Medical Imaging, Royal North Shore Hospital, Sydney, Australia.
Albert C GohDepartment of Medical Imaging, Royal North Shore Hospital, Sydney, Australia.ORCID 0000-0002-3860-8965
Yaser H GholamiSchool of Biomedical Engineering, Faculty of Engineering, University of Sydney, Sydney, Australia.ORCID 0000-0002-7161-9367
Nick PavlakisSchool of Health Sciences, Faculty of Medicine & Health, University of Sydney, Sydney, Australia.ORCID 0000-0002-1738-0316
Kathy P WillowsonDepartment of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia.ORCID 0000-0002-2195-0596

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radioembolizaton of hepatic malignancy is an accepted palliative treatment option in many subjects. The process of working up an individual for a radioembolization procedure permits pretreatment radiation dosimetry to be estimated, which is not possible with many other theranostic pairs of radionuclides. These estimates can then be used to prescribe the desired amount of radionuclide therapy (RNT), in radiation dose units of gray (Gy), to treat the cancer tissues to a desired level as well as permitting the radiation dose to the normal liver compartment to be minimized. As such, radioembolization represents an excellent example of a theranostic approach to treatment where individualization of the therapy can be highly tailored. The necessary tools are now available to implement this approach on a wider scale, which should improve outcomes for the treated individuals. The aim of this review article was to present a contemporary approach to personalized treatment planning for radioembolization and to emphasize the theranostic aspects of the process. A clinical case is presented demonstrating the potential for excellent clinical outcomes using an image-based and informed treatment plan developed by the multidisciplinary team of nuclear physicians, interventional radiologists, medical oncologists, and medical physicists.

Indexed as

hepatic malignancyliver-directed therapyradioembolizationSIRTtheranostic

Identifiers

PMID41221382
PMCPMC12602074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.